| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |